Metabolic syndrome: pathogenesis, medical care and dental implications.
Identifieur interne : 000414 ( Main/Exploration ); précédent : 000413; suivant : 000415Metabolic syndrome: pathogenesis, medical care and dental implications.
Auteurs : Arthur H. Friedlander [États-Unis] ; Jane Weinreb ; Ida Friedlander ; John A. YagielaSource :
- Journal of the American Dental Association (1939) [ 0002-8177 ] ; 2007.
Descripteurs français
- KwdFr :
- Acides gras (métabolisme), Acides gras (sang), Anorexigènes (effets indésirables), Anticholestérolémiants (effets indésirables), Diétothérapie (MeSH), Graisse abdominale (métabolisme), Humains (MeSH), Hypertension artérielle (physiopathologie), Inhibiteurs de l'enzyme de conversion de l'angiotensine (effets indésirables), Insulinorésistance (physiologie), Interactions médicamenteuses (MeSH), Maladies de la bouche (induit chimiquement), Obésité (thérapie), Soins dentaires pour malades chroniques (MeSH), Syndrome métabolique X (thérapie), Syndrome métabolique X (épidémiologie), Syndrome métabolique X (étiologie), États-Unis (épidémiologie).
- MESH :
- effets indésirables : Anorexigènes, Anticholestérolémiants, Inhibiteurs de l'enzyme de conversion de l'angiotensine.
- induit chimiquement : Maladies de la bouche.
- métabolisme : Acides gras, Graisse abdominale.
- physiologie : Insulinorésistance.
- physiopathologie : Hypertension artérielle.
- sang : Acides gras.
- thérapie : Obésité, Syndrome métabolique X.
- épidémiologie : Syndrome métabolique X, États-Unis.
- étiologie : Syndrome métabolique X.
- Diétothérapie, Humains, Interactions médicamenteuses, Soins dentaires pour malades chroniques.
English descriptors
- KwdEn :
- Abdominal Fat (metabolism), Angiotensin-Converting Enzyme Inhibitors (adverse effects), Anticholesteremic Agents (adverse effects), Appetite Depressants (adverse effects), Dental Care for Chronically Ill (MeSH), Diet Therapy (MeSH), Drug Interactions (MeSH), Fatty Acids (blood), Fatty Acids (metabolism), Humans (MeSH), Hypertension (physiopathology), Insulin Resistance (physiology), Metabolic Syndrome (epidemiology), Metabolic Syndrome (etiology), Metabolic Syndrome (therapy), Mouth Diseases (chemically induced), Obesity (therapy), United States (epidemiology).
- MESH :
- chemical , adverse effects : Angiotensin-Converting Enzyme Inhibitors, Anticholesteremic Agents, Appetite Depressants.
- chemical , blood : Fatty Acids.
- chemically induced : Mouth Diseases.
- epidemiology : Metabolic Syndrome, United States.
- etiology : Metabolic Syndrome.
- metabolism : Abdominal Fat, Fatty Acids.
- physiology : Insulin Resistance.
- physiopathology : Hypertension.
- therapy : Metabolic Syndrome, Obesity.
- Dental Care for Chronically Ill, Diet Therapy, Drug Interactions, Humans.
Abstract
BACKGROUND
The dental literature contains little information about metabolic syndrome (MetS) and its dental implications.
TYPES OF STUDIES REVIEWED
The authors conducted a MEDLINE search for the period 2000 through 2005, using the term "metabolic syndrome" to define its pathophysiology, medical treatment and dental implications.
RESULTS
MetS is the co-occurrence of abdominal obesity, hyper-triglyceridemia, reduced high-density lipoprotein cholesterol levels, hypertension and impaired fasting glucose, which results from consumption of a high-calorie diet and decreased levels of physical activity superimposed on the appropriate genetic setting. Components of MetS synergistically promote the development of atherosclerosis, resulting in myocardial infarction and stroke.
CLINICAL IMPLICATIONS
Deteriorating oral health status is associated with worsening of the atherogenic profile. Tooth loss often results in chewing difficulties because of inadequate occlusive surfaces and may lead to alterations in food selection and dietary quality. This, in turn, adversely affects body composition and nutritional status, both of which are related to vascular health. Dentists should develop treatment plans that preserve and restore the dentition, thus ensuring maximum masticatory efficiency and affording patients the optimum opportunity to consume food that will not foster atherogenesis.
DOI: 10.14219/jada.archive.2007.0134
PubMed: 17272372
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Metabolic syndrome: pathogenesis, medical care and dental implications.</title><author><name sortKey="Friedlander, Arthur H" sort="Friedlander, Arthur H" uniqKey="Friedlander A" first="Arthur H" last="Friedlander">Arthur H. Friedlander</name><affiliation wicri:level="2"><nlm:affiliation>Graduate Medical Education, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA. arthur.friedlander@med.va.gov</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Graduate Medical Education, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Weinreb, Jane" sort="Weinreb, Jane" uniqKey="Weinreb J" first="Jane" last="Weinreb">Jane Weinreb</name></author><author><name sortKey="Friedlander, Ida" sort="Friedlander, Ida" uniqKey="Friedlander I" first="Ida" last="Friedlander">Ida Friedlander</name></author><author><name sortKey="Yagiela, John A" sort="Yagiela, John A" uniqKey="Yagiela J" first="John A" last="Yagiela">John A. Yagiela</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2007">2007</date><idno type="RBID">pubmed:17272372</idno><idno type="pmid">17272372</idno><idno type="doi">10.14219/jada.archive.2007.0134</idno><idno type="wicri:Area/Main/Corpus">000421</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000421</idno><idno type="wicri:Area/Main/Curation">000421</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000421</idno><idno type="wicri:Area/Main/Exploration">000421</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Metabolic syndrome: pathogenesis, medical care and dental implications.</title><author><name sortKey="Friedlander, Arthur H" sort="Friedlander, Arthur H" uniqKey="Friedlander A" first="Arthur H" last="Friedlander">Arthur H. Friedlander</name><affiliation wicri:level="2"><nlm:affiliation>Graduate Medical Education, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA. arthur.friedlander@med.va.gov</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Graduate Medical Education, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073</wicri:regionArea><placeName><region type="state">Californie</region></placeName></affiliation></author><author><name sortKey="Weinreb, Jane" sort="Weinreb, Jane" uniqKey="Weinreb J" first="Jane" last="Weinreb">Jane Weinreb</name></author><author><name sortKey="Friedlander, Ida" sort="Friedlander, Ida" uniqKey="Friedlander I" first="Ida" last="Friedlander">Ida Friedlander</name></author><author><name sortKey="Yagiela, John A" sort="Yagiela, John A" uniqKey="Yagiela J" first="John A" last="Yagiela">John A. Yagiela</name></author></analytic><series><title level="j">Journal of the American Dental Association (1939)</title><idno type="ISSN">0002-8177</idno><imprint><date when="2007" type="published">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Abdominal Fat (metabolism)</term><term>Angiotensin-Converting Enzyme Inhibitors (adverse effects)</term><term>Anticholesteremic Agents (adverse effects)</term><term>Appetite Depressants (adverse effects)</term><term>Dental Care for Chronically Ill (MeSH)</term><term>Diet Therapy (MeSH)</term><term>Drug Interactions (MeSH)</term><term>Fatty Acids (blood)</term><term>Fatty Acids (metabolism)</term><term>Humans (MeSH)</term><term>Hypertension (physiopathology)</term><term>Insulin Resistance (physiology)</term><term>Metabolic Syndrome (epidemiology)</term><term>Metabolic Syndrome (etiology)</term><term>Metabolic Syndrome (therapy)</term><term>Mouth Diseases (chemically induced)</term><term>Obesity (therapy)</term><term>United States (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acides gras (métabolisme)</term><term>Acides gras (sang)</term><term>Anorexigènes (effets indésirables)</term><term>Anticholestérolémiants (effets indésirables)</term><term>Diétothérapie (MeSH)</term><term>Graisse abdominale (métabolisme)</term><term>Humains (MeSH)</term><term>Hypertension artérielle (physiopathologie)</term><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine (effets indésirables)</term><term>Insulinorésistance (physiologie)</term><term>Interactions médicamenteuses (MeSH)</term><term>Maladies de la bouche (induit chimiquement)</term><term>Obésité (thérapie)</term><term>Soins dentaires pour malades chroniques (MeSH)</term><term>Syndrome métabolique X (thérapie)</term><term>Syndrome métabolique X (épidémiologie)</term><term>Syndrome métabolique X (étiologie)</term><term>États-Unis (épidémiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Angiotensin-Converting Enzyme Inhibitors</term><term>Anticholesteremic Agents</term><term>Appetite Depressants</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Fatty Acids</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Mouth Diseases</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Anorexigènes</term><term>Anticholestérolémiants</term><term>Inhibiteurs de l'enzyme de conversion de l'angiotensine</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Metabolic Syndrome</term><term>United States</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Metabolic Syndrome</term></keywords><keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Maladies de la bouche</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Abdominal Fat</term><term>Fatty Acids</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Acides gras</term><term>Graisse abdominale</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Insulinorésistance</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Insulin Resistance</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Hypertension artérielle</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Hypertension</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Acides gras</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Metabolic Syndrome</term><term>Obesity</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Obésité</term><term>Syndrome métabolique X</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Syndrome métabolique X</term><term>États-Unis</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Syndrome métabolique X</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Dental Care for Chronically Ill</term><term>Diet Therapy</term><term>Drug Interactions</term><term>Humans</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Diétothérapie</term><term>Humains</term><term>Interactions médicamenteuses</term><term>Soins dentaires pour malades chroniques</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>The dental literature contains little information about metabolic syndrome (MetS) and its dental implications.</p></div><div type="abstract" xml:lang="en"><p><b>TYPES OF STUDIES REVIEWED</b></p><p>The authors conducted a MEDLINE search for the period 2000 through 2005, using the term "metabolic syndrome" to define its pathophysiology, medical treatment and dental implications.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>MetS is the co-occurrence of abdominal obesity, hyper-triglyceridemia, reduced high-density lipoprotein cholesterol levels, hypertension and impaired fasting glucose, which results from consumption of a high-calorie diet and decreased levels of physical activity superimposed on the appropriate genetic setting. Components of MetS synergistically promote the development of atherosclerosis, resulting in myocardial infarction and stroke.</p></div><div type="abstract" xml:lang="en"><p><b>CLINICAL IMPLICATIONS</b></p><p>Deteriorating oral health status is associated with worsening of the atherogenic profile. Tooth loss often results in chewing difficulties because of inadequate occlusive surfaces and may lead to alterations in food selection and dietary quality. This, in turn, adversely affects body composition and nutritional status, both of which are related to vascular health. Dentists should develop treatment plans that preserve and restore the dentition, thus ensuring maximum masticatory efficiency and affording patients the optimum opportunity to consume food that will not foster atherogenesis.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17272372</PMID><DateCompleted><Year>2007</Year><Month>03</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>07</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0002-8177</ISSN><JournalIssue CitedMedium="Print"><Volume>138</Volume><Issue>2</Issue><PubDate><Year>2007</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of the American Dental Association (1939)</Title><ISOAbbreviation>J Am Dent Assoc</ISOAbbreviation></Journal><ArticleTitle>Metabolic syndrome: pathogenesis, medical care and dental implications.</ArticleTitle><Pagination><MedlinePgn>179-87; quiz 248</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The dental literature contains little information about metabolic syndrome (MetS) and its dental implications.</AbstractText><AbstractText Label="TYPES OF STUDIES REVIEWED" NlmCategory="METHODS">The authors conducted a MEDLINE search for the period 2000 through 2005, using the term "metabolic syndrome" to define its pathophysiology, medical treatment and dental implications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">MetS is the co-occurrence of abdominal obesity, hyper-triglyceridemia, reduced high-density lipoprotein cholesterol levels, hypertension and impaired fasting glucose, which results from consumption of a high-calorie diet and decreased levels of physical activity superimposed on the appropriate genetic setting. Components of MetS synergistically promote the development of atherosclerosis, resulting in myocardial infarction and stroke.</AbstractText><AbstractText Label="CLINICAL IMPLICATIONS" NlmCategory="CONCLUSIONS">Deteriorating oral health status is associated with worsening of the atherogenic profile. Tooth loss often results in chewing difficulties because of inadequate occlusive surfaces and may lead to alterations in food selection and dietary quality. This, in turn, adversely affects body composition and nutritional status, both of which are related to vascular health. Dentists should develop treatment plans that preserve and restore the dentition, thus ensuring maximum masticatory efficiency and affording patients the optimum opportunity to consume food that will not foster atherogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Friedlander</LastName><ForeName>Arthur H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Graduate Medical Education, VA Greater Los Angeles Healthcare System, Los Angeles, CA 90073, USA. arthur.friedlander@med.va.gov</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weinreb</LastName><ForeName>Jane</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Friedlander</LastName><ForeName>Ida</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Yagiela</LastName><ForeName>John A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Dent Assoc</MedlineTA><NlmUniqueID>7503060</NlmUniqueID><ISSNLinking>0002-8177</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000806">Angiotensin-Converting Enzyme Inhibitors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000924">Anticholesteremic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001067">Appetite Depressants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005227">Fatty Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>D</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Am Dent Assoc. 2007 Jun;138(6):712, 714; author reply 714, 716</RefSource><PMID Version="1">17545256</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D050153" MajorTopicYN="N">Abdominal Fat</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000806" MajorTopicYN="N">Angiotensin-Converting Enzyme Inhibitors</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000924" MajorTopicYN="N">Anticholesteremic Agents</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001067" MajorTopicYN="N">Appetite Depressants</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017742" MajorTopicYN="Y">Dental Care for Chronically Ill</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004035" MajorTopicYN="N">Diet Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006973" MajorTopicYN="N">Hypertension</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024821" MajorTopicYN="Y">Metabolic Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009059" MajorTopicYN="N">Mouth Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009765" MajorTopicYN="N">Obesity</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>80</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>3</Month><Day>28</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>2</Month><Day>3</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17272372</ArticleId><ArticleId IdType="pii">S0002-8177(14)62125-5</ArticleId><ArticleId IdType="doi">10.14219/jada.archive.2007.0134</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Californie</li></region></list><tree><noCountry><name sortKey="Friedlander, Ida" sort="Friedlander, Ida" uniqKey="Friedlander I" first="Ida" last="Friedlander">Ida Friedlander</name><name sortKey="Weinreb, Jane" sort="Weinreb, Jane" uniqKey="Weinreb J" first="Jane" last="Weinreb">Jane Weinreb</name><name sortKey="Yagiela, John A" sort="Yagiela, John A" uniqKey="Yagiela J" first="John A" last="Yagiela">John A. Yagiela</name></noCountry><country name="États-Unis"><region name="Californie"><name sortKey="Friedlander, Arthur H" sort="Friedlander, Arthur H" uniqKey="Friedlander A" first="Arthur H" last="Friedlander">Arthur H. Friedlander</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SuicidDentistV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000414 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000414 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SuicidDentistV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:17272372
|texte= Metabolic syndrome: pathogenesis, medical care and dental implications.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:17272372" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SuicidDentistV1
| This area was generated with Dilib version V0.6.39. |  |